Bill Gates Tries to Profit by Driving Down Tesla Shares and is Confused by Elon Musk Anger

Bill Gates bet billions against Tesla in a method called short selling. Short selling involves borrowing a security from a broker and selling it on the open market. Short selling adds liquidity to a market by increasing the volume of buying and selling above normal levels. This volume would not exist without short sellers. The …

Read more

Bill Gates Praises New Advanced Nuclear Energy Legislation

The US Congress has authorized a new bill that supports the development of advanced nuclear power. Billionaire Bill Gates says “I cannot overstate how important this is”. The bill includes: long-term nuclear power purchase agreements advanced nuclear reactor research and development goals the establishment of a long-term nuclear power purchase agreement pilot programme a nuclear …

Read more

Commonwealth Fusion stronger magnet tokomak gets billionaire funding

Commonwealth Fusion Systems a spinout from MIT has received additional funding from Breakthrough Energy Ventures (which investment from billionaires Bill Gates, Jeff Bezos, Jack Ma, Mukesh Ambani, and Richard Branson). Commonwealth Fusion Systems will use new superconducting materials to make far stronger magnets for a smaller Tokamak fusion system. The planned fusion experiment, called Sparc, …

Read more

Slate reports that Bill Gates investment in Arizona land is a regular real estate investment

There was a flurry of speculation that Bill Gates was going to build a smart city in Arizona but it is almost certainly an ordinary real estate investment. Bill Gates uses Cascade Investment for investment in stocks like railways, waste removal, and agricultural equipment companies. It has real estate investments like the Four Seasons and …

Read more

Bill Gates believes Alzheimers research is a turning point and is investing $100 million to accelerate progress

Bill Gates has personally invested $50 million in the Dementia Discovery Fund—a private fund working to diversify the clinical pipeline and identify new targets for treatment. Most of the major pharmaceutical companies continue to pursue the amyloid and tau pathways. DDF complements their work by supporting startups as they explore less mainstream approaches to treating …

Read more